Literature DB >> 23958951

Identification of a cellular ligand for the natural cytotoxicity receptor NKp44.

Florence Baychelier1, Alexis Sennepin, Myriam Ermonval, Karim Dorgham, Patrice Debré, Vincent Vieillard.   

Abstract

With an array of activating and inhibitory receptors, natural killer (NK) cells are involved in the eradication of infected, transformed, and tumor cells. NKp44 is a member of the natural cytotoxicity receptor family, which is exclusively expressed on activated NK cells. Here, we identify natural cytotoxicity receptor NKp44 (NKp44L), a novel isoform of the mixed-lineage leukemia-5 protein, as a cellular ligand for NKp44. Unlike the other MLL family members, NKp44L is excluded from the nucleus, but expressed at the cell-surface level; its subcellular localization is being associated with the presence of a specific C-terminal motif. Strikingly, NKp44L has not been detected on circulating cells isolated from healthy individuals, but it is expressed on a large panel of the tumor and transformed cells. The sharply decreased NK lysis activity induced by anti-NKp44L antibodies directly demonstrates the role of NKp44L in cytotoxicity. Taken together, these results show that NKp44L could be critical for NK cell-mediated innate immunity. The identification and cellular distribution of NKp44L highlight the role of this self-molecule as a danger signal to alert the NK cell network.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23958951     DOI: 10.1182/blood-2013-03-489054

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  80 in total

1.  Found: a cellular activating ligand for NKp44.

Authors:  Sumati Rajagopalan; Eric O Long
Journal:  Blood       Date:  2013-10-24       Impact factor: 22.113

2.  Drug-induced hyperploidy stimulates an antitumor NK cell response mediated by NKG2D and DNAM-1 receptors.

Authors:  Andrea Acebes-Huerta; Seila Lorenzo-Herrero; Alicia R Folgueras; Leticia Huergo-Zapico; Carlos Lopez-Larrea; Alejandro López-Soto; Segundo Gonzalez
Journal:  Oncoimmunology       Date:  2015-08-12       Impact factor: 8.110

Review 3.  MLL5 (KMT2E): structure, function, and clinical relevance.

Authors:  Xiaoming Zhang; Wisna Novera; Yan Zhang; Lih-Wen Deng
Journal:  Cell Mol Life Sci       Date:  2017-02-10       Impact factor: 9.261

4.  IL15 induces a potent antitumor activity in NK cells isolated from malignant pleural effusions and overcomes the inhibitory effect of pleural fluid.

Authors:  D Croxatto; S Martini; L Chiossone; F Scordamaglia; C F Simonassi; L Moretta; M C Mingari; P Vacca
Journal:  Oncoimmunology       Date:  2017-02-17       Impact factor: 8.110

Review 5.  Clinical utility of natural killer cells in cancer therapy and transplantation.

Authors:  David A Knorr; Veronika Bachanova; Michael R Verneris; Jeffrey S Miller
Journal:  Semin Immunol       Date:  2014-03-05       Impact factor: 11.130

Review 6.  NK cells after transplantation: friend or foe.

Authors:  Uzi Hadad; Olivia Martinez; Sheri M Krams
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

7.  NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures.

Authors:  Paolo Carrega; Fabrizio Loiacono; Emma Di Carlo; Angelo Scaramuccia; Marco Mora; Romana Conte; Roberto Benelli; Grazia Maria Spaggiari; Claudia Cantoni; Stefania Campana; Irene Bonaccorsi; Barbara Morandi; Mauro Truini; Maria Cristina Mingari; Lorenzo Moretta; Guido Ferlazzo
Journal:  Nat Commun       Date:  2015-09-23       Impact factor: 14.919

8.  Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts.

Authors:  Natasja Nielsen; Veronique Pascal; Andreas E R Fasth; Yvonne Sundström; Elisabeth D Galsgaard; David Ahern; Martin Andersen; Bo Baslund; Else M Bartels; Henning Bliddal; Marc Feldmann; Vivianne Malmström; Louise Berg; Pieter Spee; Kalle Söderström
Journal:  Immunology       Date:  2014-08       Impact factor: 7.397

9.  TGF-β-inducible microRNA-183 silences tumor-associated natural killer cells.

Authors:  Sarah S Donatelli; Jun-Min Zhou; Danielle L Gilvary; Erika A Eksioglu; Xianghong Chen; W Douglas Cress; Eric B Haura; Matthew B Schabath; Domenico Coppola; Sheng Wei; Julie Y Djeu
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-28       Impact factor: 11.205

10.  The Stalk Domain of NKp30 Contributes to Ligand Binding and Signaling of a Preassembled NKp30-CD3ζ Complex.

Authors:  Stefanie Memmer; Sandra Weil; Steffen Beyer; Tobias Zöller; Eike Peters; Jessica Hartmann; Alexander Steinle; Joachim Koch
Journal:  J Biol Chem       Date:  2016-10-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.